Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

129.58 -2.29 (-1.74%)
Streaming Delayed Price Updated: 1:06 PM EDT, May 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
30 31 Next >
Best ETFs, Funds, and Stocks of 2022. A Preview to 2023.
In 2022, high inflation and rising bond yields emerged as headwinds for stocks. The S&P 500 declined by over 18%, marking its worst yearly showing since 2008. 
Via Talk Markets
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
Small-cap speculative biotech stocks regain interest with volatility. 
Via Talk Markets
Market Awaits The CPI And Financial Earnings - Be Ready!
A look at the upcoming big events this week, which stocks are leading the rally with double-digit gains so far in 2023 and which smaller number of stocks started the year weak. 
Via Talk Markets
Biden, Trump, DeSantis: Cramer Says Concerns Over Next President Mean We May Be In For 'Second Leg' Of 'Vicious Rotation' Out Of Healthcare
The Health Care Select Sector SPDR Fund (NYSE: XLV) ended 2022 with a modest loss of 2.08%, a relative outperformance vis-a-vis the broader S&P 500 Index, 
Via Benzinga
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk. 
Via The Motley Fool
Budding Sign Not To Miss
Encouraging signs from corporate junk bonds, stocks are likely to get a tailwind to open 2023. 
Via Talk Markets
Small-Caps Set To Sizzle
Via Talk Markets
Leading And Lagging Sectors For January 3, 2023
Gainers Symbol Name Price Change ($) Change (%) Volume 
Via Benzinga
Investing In 2023 - The Crucial Events Driving The Markets
Business decisions drive the business cycle. These decisions will impact the markets in 2023 and beyond. 
Via Talk Markets
The Year In Review And Ahead
We‘ll continue witnessing cost-push inflation combined with tight labor market – and it would be crude oil‘s time again to gain in value from current levels. 
Via Talk Markets
2022 Review: US Equity Sectors
Annual returns for equity sectors are always a study in contrasts, but the blowout performance of energy stocks in 2022 is unusually divergent vs. the rest of the field. 
Via Talk Markets
AI Stock Forecast: Fighting The Irrational Crowd By Investing Through AI
Deviation from rational thinking creates direct losses or opportunity costs in investing activity. AI can capture our biases and feelings, and uncover the knowledge that is covered for a general... 
Via Talk Markets
Has The Final Leg Of The Bear Market Begun?
The S&P 500 experienced a momentum reversal this week. What can we learn from history and a wide variety of charts and data sets? 
Via Talk Markets
Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead
Healthcare stocks are now favored by many strategists because of their defensive nature and focus on US markets. 
Via Talk Markets
A Stalwart Delivers
Since August, volatility has risen for all S&P 500 sectors, with Consumer Discretionary and Energy maintaining their status as the most volatile sectors. 
Via Talk Markets
Leading And Lagging Sectors For November 18, 2022
Gainers Symbol Name Price Change ($) Change (%) Volume 
Via Benzinga
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry. 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
The (Alarm) Bells Are Ringing For Me And My Gal
It is entirely reasonable with persistent inflation at current levels for S&P 500 earnings to come down to levels far lower than currently projected. 
Via Talk Markets
Visualizing S&P 500 Performance In 2022, By Sector
Tracking indexes over the course of a year reveals a lot about market trends and sentiment. The S&P 500’s performance over the course of 2022 is a great example. 
Via Talk Markets
A Stagflation Storm
A discussion about the trifecta of trends that caused the current inflationary environment, why an economic slowdown won’t cure inflation, and the three sectors every investor should own today. 
Via Talk Markets
UnitedHealth Is a Blue Chip Stock You Can't Afford Not to Buy
The health insurer's stock performance has crushed the S&P 500 index year to date. 
Via The Motley Fool
Why The Next (Likely) Global Recession May Be Different Type Of Bear All Along
While it’s helpful to look back at past bear markets for guidance, it’s also important to remember that the current market conditions are not the same as they were in 1999 or 2007. 
Via Talk Markets
Can Molina Healthcare Sustain Its Market-Beating Rally?
While bigger industry peers get more attention, large-cap managed-care provider Molina shows better price strength as well as solid earnings and revenue growth. 
Via MarketBeat
Topics ETFs
Picking Stocks In A Bond-Friendly Environment
Picking the right stocks instead of the most popular ones may be more rewarding than investors have grown accustomed to. 
Via Talk Markets
Steady As She Goes With Healthcare Stocks
Favorable seasonality lies ahead for Q4 with a caveat of Q3 earnings reports. 
Via Talk Markets
Weekly Market Pulse: Just A Little Volatility
Volatility is the inverse of liquidity. When there is ample liquidity there is little volatility and when there is none we get lots of it. 
Via Talk Markets
Leading And Lagging Sectors For October 12, 2022
Gainers Symbol Name Price Change ($) Change (%) Volume 
Via Benzinga
Stocks Are In La La Land… Just Like They Were Right Before Lehman
The current rally in stocks is on borrowed time. Enjoy it while it lasts. 
Via Talk Markets
Stocks And Sectors With The Biggest Declines
The average stock in the Russell 3,000 was down 41.7% from its 52-week high as of the close yesterday. That means the average stock would need to rally 71.5% from here to get back to its high. 
Via Talk Markets
Can Healthcare Stocks Continue To Outperform?
Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis. 
Via Talk Markets
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.